Dr. Prince Anand, Ph.D.: h-index, Total Citations, and Citation Map
Dr. Prince Anand, Ph.D.'s h-index is 8 (4 i10-index, 263+ total citations across 19+ publications) according to Google Scholar as of May 2026. Dr. Prince Anand, Ph.D. is affiliated with Postdoctoral Scientist, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Dr. Prince Anand, Ph.D. is a researcher affiliated with Postdoctoral Scientist, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, specializing in Cancer Biology, Drug development, Drug discovery. Their work has been cited 263 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Dr. Prince Anand, Ph.D.'s Citation Metrics
Bibliometric impact based on 19 indexed publications.
- H-Index
- 8
- i10-Index
- 4
- Total Citations
- 263
- Citing Countries
- 14
As of May 2026.
Dr. Prince Anand, Ph.D. has an h-index of 8 and 263 total citations across 19 publications, with research cited by institutions in 14 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Dr. Prince Anand, Ph.D.'s citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression
2019160
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
122 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher identified MAPKAPK2 as a master regulator of RNA-binding proteins and subsequently developed novel MK2 inhibitors to target this pathway in head and neck squamous cell carcinoma.
The researcher developed an amorphous solid dispersion strategy to enhance phloretin bioavailability and therapeutic efficacy against NAFLD by targeting the mTOR/SREBP-1c axis.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
